JP4332468B2 - Cosmetics - Google Patents
Cosmetics Download PDFInfo
- Publication number
- JP4332468B2 JP4332468B2 JP2004143165A JP2004143165A JP4332468B2 JP 4332468 B2 JP4332468 B2 JP 4332468B2 JP 2004143165 A JP2004143165 A JP 2004143165A JP 2004143165 A JP2004143165 A JP 2004143165A JP 4332468 B2 JP4332468 B2 JP 4332468B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- fragrance
- cosmetic product
- salt
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 64
- 239000003205 fragrance Substances 0.000 claims description 70
- 229920002125 Sokalan® Polymers 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 20
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 claims description 12
- 239000002736 nonionic surfactant Substances 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 8
- 241000207199 Citrus Species 0.000 claims description 5
- 206010022998 Irritability Diseases 0.000 claims description 5
- 235000020971 citrus fruits Nutrition 0.000 claims description 5
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 239000000047 product Substances 0.000 description 31
- -1 polyoxyethylene Polymers 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 230000008859 change Effects 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- 229920001296 polysiloxane Polymers 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 239000001593 sorbitan monooleate Substances 0.000 description 7
- 235000011069 sorbitan monooleate Nutrition 0.000 description 7
- 229940035049 sorbitan monooleate Drugs 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- 235000010493 xanthan gum Nutrition 0.000 description 7
- 239000000230 xanthan gum Substances 0.000 description 7
- 229940082509 xanthan gum Drugs 0.000 description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical group CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000008786 sensory perception of smell Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical group CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical group CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- OYXVDHZABMXCMX-UHFFFAOYSA-N 2-decyltetradecanoic acid Chemical group CCCCCCCCCCCCC(C(O)=O)CCCCCCCCCC OYXVDHZABMXCMX-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Description
本発明は香粧品に関し、更に詳細には、コロン、オードパルファム、オーデコロン、ボディコロンなどに好適な香粧品に関する。 The present invention relates to cosmetics, and more particularly to cosmetics suitable for colons, eau de parfum, eau de cologne, body colons and the like.
コロン、オードパルファム、オーデコロン、ボディコロンなどの香粧品は、嗅覚を刺激して、心身に好ましい影響を与えたり、他人の印象形成に好ましく働かせたりすることを目的とする化粧料であり、その必要な要件としては、適当な種類の、適当な強度の嗅覚刺激を、その種類と強度が変化しないで長時間維持することが挙げられる。しかしながら、香料を構成する香気成分の種類は極めて多く、しかも、それぞれが異なった気化速度を有しているため、香気が速やかに消失したり、香気の種類や強さが異なってしまう欠点が存している。一方、かかる香料成分の心身などに与える影響としては、リラクゼーション、心のいらいら、くよくよと言った抑圧を解放し、安定化する精神安定化作用や免疫賦活作用などが存することが知られており（例えば、特許文献１、特許文献２を参照）、この様な効果の発現のためには、前記のような香料の香調の変化は大きな障害になっていることも否めない。即ち、香粧品に於いて、その香調の変化を抑制し、香りの持続性を高めることは、常に望まれていることであり、その為の努力が為されている。 Cosmetics such as colon, eau de parfum, eau de cologne, and body colon are cosmetics intended to stimulate the sense of smell and have a positive effect on the mind and body, and to make it more favorable for the impression formation of others. The requirement includes maintaining an appropriate type of olfactory stimulus of an appropriate intensity for a long time without changing the type and intensity. However, there are many types of fragrance components that constitute fragrances, and each has a different vaporization rate, so there is a drawback that the fragrance disappears quickly or the type and intensity of the fragrance differ. is doing. On the other hand, it is known that the effects of such perfume ingredients on the mind and body include relaxation, mental anxiety, and immunostimulatory action that releases and stabilizes the suppression of mental irritations. For example, see Patent Document 1 and Patent Document 2), and it cannot be denied that the change in the fragrance of the fragrance as described above is a major obstacle for the manifestation of such effects. That is, in cosmetics, it is always desired to suppress the change of the scent and enhance the sustainability of the scent, and efforts are being made for that purpose.
香粧品に於いて、その香調の変化を抑制し、香りの持続性を高める技術としては、例えば、多孔質粉体を利用する方法、水膨潤性樹脂に水性成分とともに香気成分を封入する方法、中空の樹脂粉体の空隙に香気成分をリザーブさせる方法などが存するが、（例えば、特許文献３、特許文献４、特許文献５、特許文献６）これらの技術では何れも、香気の発現は持続できても、香調の変化には対応できなかった。又、乳化技術を利用して、乳化滴に香料を内包し、その香りの変化の抑制と、持続性を高める試みも為されているが（例えば、特許文献７、特許文献８、特許文献９、特許文献１０を参照）香りの立ちが著しく阻害される、製剤において、香料のイメージとはかけ離れた香りになってしまうなどの欠点が存する。又、香りの維持性もあまり向上しているとは言えない。 In cosmetics, for example, a method using porous powder or a method of encapsulating a fragrance component together with an aqueous component in a water-swellable resin as a technique for suppressing the change in fragrance and enhancing the scent sustainability There are methods for reserving fragrance components in the voids of hollow resin powders (for example, Patent Document 3, Patent Document 4, Patent Document 5, and Patent Document 6). Even if it could be sustained, it could not cope with the change in incense tone. In addition, attempts have been made to include a fragrance in emulsified droplets by using an emulsification technique, and to suppress the change in the scent and increase the sustainability (for example, Patent Document 7, Patent Document 8, and Patent Document 9). , See Patent Document 10) There are drawbacks in that the fragrance is remarkably inhibited, and the preparation has a fragrance far from the image of the fragrance. Moreover, it cannot be said that the maintenance property of fragrance is improved so much.
本発明は、この様な状況下為されたものであり、香粧品に於いて、その香調の変化を抑制し、香りの持続性を高める技術を提供することを課題とする。 The present invention has been made under such circumstances, and an object of the present invention is to provide a technique for suppressing a change in the scent of a cosmetic product and enhancing the scent sustainability.
この様な状況に鑑みて、本発明者らは、香粧品に於いて、その香調の変化を抑制し、香りの持続性を高める技術を求めて、鋭意研究努力を重ねた結果、乳化形態の香粧品であって、１）香料７〜２０質量％と２）分岐脂肪酸のトリグリセライドを１〜５質量％とを含有する香粧品が、その様な特性を有することを見出し、発明を完成させるに至った。即ち、本発明は以下に示すとおりである。尚、本発明に言う香粧品とは、身体に香気を付与するための化粧料、香料の嗅覚刺激を利用する目的で身体に塗布する化粧料、身体の臭いを香料によりマスクする目的で使用される化粧料及び香料の嗅覚刺激により、身体の機能に変化を持たせる目的で使用される化粧料の総称を意味する。
（１）乳化形態の香粧品であって、１）香調が、シトラスであることを特徴とする香料７〜２０質量％と２）グリセリルトリイソステアレートを１〜５質量％とを含有することを特徴とする、香粧品。
（２）界面活性剤として、ＨＬＢ９〜１２の非イオン界面活性剤を０．１〜１質量％含有することを特徴とする、（１）に記載の香粧品。
（３）前記ＨＬＢ９〜１２の非イオン界面活性剤が、ポリオキシエチレンソルビタンモノオレートであることを特徴とする、（２）に記載の香粧品。
（４）含有する非イオン界面活性剤が、ポリオキシエチレンソルビタンモノオレートのみであることを特徴とする、（３）に記載の香粧品。
（５）更に、アルキル変性されていても良いカルボキシビニルポリマー及び／又はその塩を含有することを特徴とする、（１）〜（４）何れかに記載の香粧品。
（６）アルキル変性されていても良いカルボキシビニルポリマー及び／又はその塩として、１）アルキル変性カルボキシビニルポリマー及び／又はその塩と２）カルボキシビニルポリマー及び／又はその塩とを含有することを特徴とする、（５）に記載の香粧品。
（７）エステティックに於いて、心のいらいらとくよくよとを改善するために身体に投与されるものであることを特徴とする、（１）〜（６）の何れかに記載の香粧品。
In view of such a situation, the present inventors have sought to develop a technique for suppressing the change in the scent of the fragrance and increasing the sustainability of the fragrance in cosmetics. It is found that a cosmetic product containing 1) 7-20% by mass of perfume and 2) 1-5% by mass of triglyceride of a branched fatty acid has such characteristics and completes the invention. It came to. That is, the present invention is as follows. The cosmetics referred to in the present invention are used for cosmetics for imparting fragrance to the body, cosmetics applied to the body for the purpose of utilizing the olfactory stimulation of the fragrances, and for masking the odors of the body with the fragrances. It is a generic term for cosmetics used for the purpose of giving changes to the functions of the body by olfactory stimulation of the cosmetics and fragrances.
(1) A cosmetic product in an emulsified form, 1) containing 7 to 20% by mass of a fragrance characterized by citrus tone, and 2) 1 to 5% by mass of glyceryl triisostearate A cosmetic product characterized by that.
(2) as a surfactant, characterized by containing a nonionic surfactant HLB9～12 0.1 to 1 wt%, cosmetics mounting serial in (1).
(3) a nonionic surfactant of the HLB9~12, characterized in that a polyoxyethylene sorbitan monooleate, cosmetics according to (2).
( 4 ) The cosmetic product according to (3) , wherein the nonionic surfactant contained is only polyoxyethylene sorbitan monooleate.
( 5 ) The cosmetic according to any one of (1) to (4 ), further comprising an alkyl-modified carboxyvinyl polymer and / or a salt thereof.
( 6 ) As a carboxyvinyl polymer which may be alkyl-modified and / or a salt thereof, it contains 1) an alkyl-modified carboxyvinyl polymer and / or a salt thereof and 2) a carboxyvinyl polymer and / or a salt thereof. The cosmetic according to (5) .
( 7 ) The cosmetic product according to any one of ( 1) to (6), wherein the cosmetic product is administered to the body in order to improve irritability and irritability.
本発明によれば、香粧品に於いて、その香調の変化を抑制し、香りの持続性を高める技術を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, in the cosmetics, the technique which suppresses the change of the fragrance | flavor and raises fragrance sustainability can be provided.
（１）本発明の香粧品の必須成分である香料
本発明の香粧品は、乳化形態の香粧品であって、香料を７〜２０質量％、より好ましくは７〜１０質量％を含有することを特徴とする。ここで、本発明に言う、香料とは、天然物より抽出された成分或いは該天然成分を化学的に誘導して得られた成分、化学的に合成された成分乃至はそれらの集合体であって、人間の嗅覚に刺激をもたらすものの総称であり、通常化粧料などに専ら賦香する目的で使用される組成物を意味する。かかる定義は世間一般に流布している香料の定義と相違しない。香料は、本発明の香粧品に於いては、その機能たる、身体に香気を付与する、香料の嗅覚刺激を利用する、身体の臭いをマスクする或いは嗅覚刺激により、身体の機能に変化を持たせる作用の主となる成分であり、かかる量比を含有することにより、その香調の変化を抑制し、香りを持続させる効果を発揮する。即ち、香料の含有量が、前記の量比より少ない場合、嗅覚刺激が充分行われない場合が存し、多すぎると香調の変化が著しくなる場合が存する。本発明の香粧品に使用する香料としては、その香調がシトラスに分類されるものが好ましく、かかるシトラスの香調の香料のもつ、心のいらいら、くよくよを改善する作用を利用することが好ましい。かかる香調の香料は、一般的に香調の変化著しいことが知られており、この為、前記の目的で香料を利用した場合、かかる効果の発現にムラがあることが知られている。本発明の香粧品の特性を利用すれば、この様な香調の変化が抑制できるため、再現性良く、且つ、確実にこの様な効果を発現させることが出来る。
(1) Perfume which is an essential component of the cosmetic product of the present invention The cosmetic product of the present invention is an emulsified cosmetic product, and contains 7 to 20% by mass, more preferably 7 to 10% by mass. It is characterized by. Here, the fragrance referred to in the present invention is a component extracted from a natural product, a component obtained by chemically deriving the natural component, a chemically synthesized component or a collection thereof. In general, it is a generic name for stimulating human olfaction, and means a composition that is usually used for the purpose of fragrance exclusively in cosmetics and the like. Such a definition is not different from the definition of fragrances that are widely distributed. In the cosmetics of the present invention, the fragrance imparts fragrance to the body, uses the olfactory stimulation of the fragrance, masks the odor of the body, or changes the body function by olfactory stimulation. It is a main component of the function to make it, and by containing such a quantitative ratio, the effect of suppressing the change in the scent and maintaining the scent is exhibited. That is, when the content of the fragrance is less than the above-mentioned amount ratio, there are cases where the olfactory stimulation is not sufficiently performed, and when there is too much, the change in the fragrance may be remarkable. As the fragrance used in the cosmetic product of the present invention, those whose fragrance is classified as citrus are preferable, and it is preferable to utilize the effect of improving the irritability and dullness of the fragrance of such citrus. . It is known that such a fragrance-like fragrance generally has a remarkable change in the fragrance, and therefore, when the fragrance is used for the above-mentioned purpose, it is known that the effect is uneven. If the characteristics of the cosmetic product of the present invention are used, such a change in fragrance can be suppressed, so that such an effect can be surely exhibited with good reproducibility.
（２）本発明の香粧品の必須成分である分岐脂肪酸のトリグリセライド
本発明の香粧品は、必須成分として、分岐脂肪酸のトリグリセライドを１〜５質量％、より好ましくは、１．５〜３質量％を含有することを特徴とする。かかる含有量は、前記香料の含有量の１／２〜１／６の量であることが好ましい。又、前記分岐脂肪酸のトリグリセライドを構成する分岐脂肪酸残基としては、炭素数８〜３０のものが好ましく、炭素数１２〜２０のものが特に好ましい。具体的には、２−エチルヘキサン酸残基、イソパルミチン酸残基、イソステアリン酸残基、オクチルドデカン酸残基、ドデシルドデカン酸残基等が好適に例示できる。これらの内、特に好ましいものは、イソパルミチン酸残基、イソステアリン酸残基、オクチルドデカン酸残基であり、イソステアリン酸残基が特に好ましい。即ち、当該トリグリセライドとしては、イソステアリン酸トリグリセライド（グリセリルトリイソステアレート）が特に好ましい。これは、かかる成分が香料の気化を、香調を崩さずに抑制し、調整するためである。かかる成分の含有量が少なすぎる場合には、香料の気化調整が十分でなく、香調を崩したり、香気の持続性を損なう場合が存し、多すぎると、香気の立ちが充分ではない場合が存するためである。
(2) Triglyceride of branched fatty acid which is an essential component of the cosmetic product of the present invention The cosmetic product of the present invention contains 1 to 5% by mass, more preferably 1.5 to 3% by mass of triglyceride of branched fatty acid as an essential component. It is characterized by containing. Such content is preferably 1/2 to 1/6 of the content of the fragrance. Moreover, as a branched fatty acid residue which comprises the triglyceride of the said branched fatty acid, a C8-C30 thing is preferable and a C12-C20 thing is especially preferable. Specifically, 2-ethylhexanoic acid residue, isopalmitic acid residue, isostearic acid residue, octyldodecanoic acid residue, dodecyldodecanoic acid residue and the like can be preferably exemplified. Of these, particularly preferred are an isopalmitic acid residue, an isostearic acid residue, and an octyldodecanoic acid residue, with an isostearic acid residue being particularly preferred. That is, as the triglyceride, isostearic acid triglyceride (glyceryl triisostearate) is particularly preferable. This is because such components suppress and adjust the vaporization of the fragrance without destroying the fragrance. If the content of such ingredients is too small, the fragrances may not be adequately vaporized, and there may be cases where the fragrance is damaged or the sustainability of the fragrance is impaired. This is because there exists.
（３）本発明の香粧品
本発明の香粧品は、前記必須成分を含有し、乳化剤形を取ることを特徴とする。前記乳化剤形としては、油中水乳化剤形でも、水中油乳化剤形でも、多相乳化剤形でも使用可能であるが、水中油乳化剤形を取ることが、前記香調の安定化効果と香り持続効果を具現化する上で特に好ましい。かかる乳化剤形を取るためには、界面活性剤を使用することを要するが、かかる界面活性剤としては、ＨＬＢ（親水性親油性バランス）９〜１２の非イオン界面活性剤を用いることが好ましく、前記ＨＬＢ（親水性親油性バランス）９〜１２の非イオン界面活性剤としては、ポリオキシエチレン（６）ソルビタンモノ脂肪酸エステルを用いることが好ましく、前記ポリオキシエチレン（６）ソルビタンモノ脂肪酸エステルとしては、ポリオキシエチレン（６）ソルビタンモノオレートを用いることが好ましい。かかる界面活性剤の含有量は、総量で、香粧品全量に対して、０．１〜１質量％、より好ましくは０．２〜０．８質量％含有することが好ましい。更に、安定な乳化系を維持するためには、アルキル変性されていても良い、カルボキシビニルポリマー及び／又はその塩を含有することが好ましく、より好ましくはアルキル変性されたカルボキシビニルポリマー及び／又はその塩を含有することがより好ましい。アルキル変性されたカルボキシビニルポリマーにおいて、前記アルキル基としては、炭素数１０〜３０のものが好ましく、かかるアルキル基の炭素鎖は唯一種であっても、分布を有していても良い。この様なアルキル変性されたカルボキシビニルポリマーは既に化粧料原料として市販されているものが存し、それを購入して利用することが出来る。この様な市販品としては、例えば、炭素数１
０〜３０のアルキル基を有し、且つ、架橋構造を有するカルボキシビニルポリマーである、グッドリッチ社より販売されている「カーボポール１３８２」（アクリル酸（Ｃ１０〜３０）アルキル・メタクリル酸クロスリンクド（架橋）コポリマー）、「ペムレンＴＲ−１」（アクリル酸ステアリル・メタクリル酸クロスリンクド（架橋）コポリマー）等が例示でき、アルキル基を有する「カーボポール１３８２」（アクリル酸（Ｃ１０〜３０）アルキル・メタクリル酸クロスリンクド（架橋）コポリマー）等が好ましく例示できる。中でも、「カーボポール１３８２」（アクリル酸（Ｃ１０〜３０）アルキル・メタクリル酸クロスリンクド（架橋）コポリマー）が特に好ましい。又、これらの塩としては、ナトリウム塩、カリウム塩等のアルカリ金属塩、カルシウム、マグネシウム等のアルカリ土類金属塩、アンモニウム塩、トリエタノールアミン塩、トリエチルアミン塩等の有機アミン塩類、リジン塩、アルギニン塩等の塩基性アミノ酸塩等が好ましく例示できる。これらは唯一種を使用することも出来るし、二種以上を組み合わせて含有させることも出来る。又、アルキル変性されていないカルボキシビニルポリマー及び／又は塩も同時に含有させることが本発明の香粧品としては好ましい。本発明の香粧品に於ける、アルキル変性されていても良いカルボキシビニルポリマーの好ましい含有量は、総量で、０．１〜５質量％であり、より好ましくは０．３〜１質量％である。又、好ましい含有形態としては、アルキル変性されたカルボキシビニルポリマー０．０１〜０．１質量％とを含有する形態である。この様な形態を取ることにより、香料の香調を変えずに香気の維持時間を長くすることが出来る。
(3) Cosmetic Product of the Present Invention The cosmetic product of the present invention is characterized by containing the essential components and taking an emulsifier form. The emulsifier form can be used as a water-in-oil emulsifier form, an oil-in-water emulsifier form, or a multi-phase emulsifier form. Is particularly preferable in realizing the above. In order to take such an emulsifier form, it is necessary to use a surfactant. As such a surfactant, it is preferable to use a nonionic surfactant having an HLB (hydrophilic lipophilic balance) of 9 to 12, Examples of the nonionic surfactant of the HLB (hydrophilic-lipophilic balance) 9-12, it is preferable to use a polyoxyethylene (6) sorbitan mono fatty acid esters, wherein the polyoxyethylene (6) Sorubitanmo Bruno fatty acid ester It is preferable to use polyoxyethylene (6) sorbitan monooleate. The total content of the surfactant is 0.1 to 1% by mass, more preferably 0.2 to 0.8% by mass, based on the total amount of the cosmetic product. Furthermore, in order to maintain a stable emulsification system, it is preferable to contain an alkyl-modified carboxyvinyl polymer and / or a salt thereof, more preferably an alkyl-modified carboxyvinyl polymer and / or a salt thereof. More preferably, it contains a salt. In the alkyl-modified carboxyvinyl polymer, the alkyl group preferably has 10 to 30 carbon atoms, and the carbon chain of the alkyl group may be a single species or may have a distribution. Such an alkyl-modified carboxyvinyl polymer already exists on the market as a cosmetic raw material, and can be purchased and used. As such a commercial product, for example, carbon number 1
“Carbopol 1382” (acrylic acid (C10-30) alkyl / methacrylic acid cross-linked, which is a carboxyvinyl polymer having 0-30 alkyl groups and a crosslinked structure, sold by Goodrich. (Crosslinked copolymer), “Pemlen TR-1” (stearyl acrylate / methacrylic acid crosslinked (crosslinked) copolymer) and the like, and “Carbopol 1382” (acrylic acid (C10-30) alkyl having an alkyl group) Preferred examples include methacrylic acid cross-linked (cross-linked) copolymer). Among them, “Carbopol 1382” (acrylic acid (C10-30) alkyl / methacrylic acid crosslinked (crosslinked) copolymer) is particularly preferable. These salts include alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as calcium and magnesium, organic amine salts such as ammonium salt, triethanolamine salt and triethylamine salt, lysine salt and arginine. Preferred examples include basic amino acid salts such as salts. These can use only a seed | species, and can also contain it in combination of 2 or more type. Moreover, it is preferable for the cosmetic product of the present invention to contain a carboxyvinyl polymer and / or a salt which is not alkyl-modified at the same time. The total content of the carboxyvinyl polymer which may be alkyl-modified in the cosmetic of the present invention is 0.1 to 5% by mass, more preferably 0.3 to 1% by mass in total. . Moreover, as a preferable containing form, it is a form containing 0.01-0.1 mass% of alkyl-modified carboxy vinyl polymers. By taking such a form, it is possible to lengthen the fragrance maintenance time without changing the fragrance of the fragrance.
本発明の香粧品に於いては、前記の成分以外に、本発明の効果を損なわない範囲に於いて、通常化粧料で使用される任意の成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類、流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−２−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−２−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−２−ヘプチルウンデカン酸グリセリン、テトラ−２−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類、脂肪酸セッケン（ラウリン酸ナトリウム、パルミチン酸ナトリウム等）、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類、塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類、イミダゾリン系両性界面活性剤（２−ココイル−２−イミダゾリニウムヒドロキサイド−１−カルボキシエチロキシ２ナトリウム塩等）、ベタイン系界面活性剤（アルキルベタイン、アミドベタイン、スルホベタイン等）、アシルメチルタウリン等の両性界面活性剤類、ポリエチレングリコール、グリセリン、１，３−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、１，２−ペンタンジオール、２，４−ヘキシレングリコール、１，２−ヘキサンジオール、１，２−オクタンジオール等の多価アルコール類、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸，ローカストビーンガム，サクシノグルカン，カロニン酸，キチン，キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレングリコール、ベントナイト等の増粘剤、表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸（シリカ）、酸化アルミニウム、硫酸バリウム等の粉体類、表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類、表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類、レーキ化されていても良い赤色２０２号、赤色２２８号、赤色２２６号、黄色４号、青色４０４号、黄色５号、赤色５０５号、赤色２３０号、赤色２２３号、橙色２０１号、赤色２１３号、黄色２０４号、黄色２０３号、青色１号、緑色２０１号、紫色２０１号、赤色２０４号等の有機色素類、ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類、パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤、糖系紫外線吸収剤、２−（２’−ヒドロキシ−５’−ｔ−オクチルフェニル)ベンゾトリアゾール、４−メトキシ−４’−ｔ−ブチルジベンゾイルメタン等の紫外線吸収剤類、エタノール、イソプロパノール等の低級アルコール類、ビタミンＡ又はその誘導体、ビタミンＢ6塩酸塩，ビタミンＢ6トリパルミテート，ビタミンＢ6ジオクタノエート，ビタミンＢ2又はその誘導体，ビタミンＢ12，ビタミンＢ15又はその誘導体等のビタミンＢ類、α−トコフェロール，β−トコフェロール，γ−トコフェロール，ビタミンＥアセテート等のビタミンＥ類、ビタミンＤ類、ビタミンＨ、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類などが好ましく例示できる。本発明の香粧品はかかる成分を常法に従って処理することにより製造することが出来る。かくして得られた、本発明の香粧品は、優れた香調維持性と、香気維持性を有するため、嗅覚を刺激して得られる、シトラスの香調の香料のもつ、心のいらいら、くよくよを改善する作用を確実に、且つ、効率よく発現させることが出来る。この為、エステティックの際に身体の施術の際に用いる、身体用の香粧品として用いることが好ましい。 In the cosmetic of the present invention, in addition to the above-mentioned components, any component that is usually used in cosmetics can be contained within a range not impairing the effects of the present invention. Such optional ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil Oils such as hardened oil, mole, hardened castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax, higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl Alcohol, behenyl alcohol, octyldodecanol, higher alcohol such as myristyl alcohol, cetostearyl alcohol, cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Synthetic ester oils such as diisostearyl, ethylene glycol di-2-ethylhexanoate, neopentyl glycol dicaprate, glycerin di-2-heptylundecanoate, pentane erythritol tetra-2-ethylhexanoate, dimethylpolysiloxane, Chain polysiloxane such as methylphenyl polysiloxane and diphenyl polysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, Oils such as silicone oils such as cyclic polysiloxanes such as kamethylcyclohexanesiloxane, amino-modified polysiloxanes, polyether-modified polysiloxanes, alkyl-modified polysiloxanes, modified polysiloxanes such as fluorine-modified polysiloxanes, fatty acid soaps (sodium laurate) , Sodium palmitate, anionic surfactants such as potassium lauryl sulfate and alkyl sulfate triethanolamine ether, cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride and laurylamine oxide, imidazoline-based amphoteric interfaces Activators (2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkylbetaines, amidebetaines, sulfos) Betaine), amphoteric surfactants such as acylmethyltaurine, polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1 , 2-pentanediol, 2,4-hexylene glycol, 1,2-hexanediol, polyhydric alcohols such as 1,2-octanediol, moisturizing ingredients such as sodium pyrrolidonecarboxylate, lactic acid, sodium lactate, guar gum , Quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydro Cypropylcellulose, chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran, kerato sulfate, locust bean gum, sac Sinoglucan, caronic acid, chitin, chitosan, carboxymethylchitin, agar, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, sodium polyacrylate, polyethylene glycol, bentonite, etc., the surface may be treated, Powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silica (silica), aluminum oxide, barium sulfate The surface may be treated, bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide inorganic pigments, the surface may be treated, mica titanium, Pearls such as fish phosphorus foil, bismuth oxychloride, red 202, red 228, red 226, yellow 4, blue 404, yellow 5, red 505, red 230, which may be raked No., Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204, organic dyes, polyethylene powder, polymethyl methacrylate , Nylon powder, organic powders such as organopolysiloxane elastomer, paraaminobenzoic acid UV absorber, anthranilic acid UV absorber, salicylic acid UV absorber, cinnamon Acid UV absorber, benzophenone UV absorber, sugar UV absorber, 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole, 4-methoxy-4′-t-butyldibenzoylmethane UV absorbers such as ethanol, lower alcohols such as ethanol, isopropanol, vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives, vitamin B12, vitamin B15 or its Vitamin B such as derivatives, vitamin E such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone, etc. are preferable It can be illustrated. The cosmetic product of the present invention can be produced by treating these components according to a conventional method. The cosmetic product of the present invention thus obtained has excellent fragrance maintenance and fragrance maintenance. Therefore, the irritating citrus fragrance obtained by stimulating the sense of smell has the irritating and irritating spirit. The improving action can be surely and efficiently expressed. For this reason, it is preferable to use it as a cosmetic product for the body, which is used for body treatment during esthetics.
以下に、実施例を挙げて、本発明について更に詳細に説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。 Hereinafter, the present invention will be described in more detail with reference to examples, but it is needless to say that the present invention is not limited to such examples.
以下に示す処方に従って、本発明の香粧品である身体用のフレグランスを作成した。即ち、イ、ロ、ハの成分をそれぞれ８０℃に加熱し、イに徐々にロを加え乳化し、更に攪拌を続けながら、ハを加えて中和し、攪拌冷却して、４０℃でニの成分を加え、更に攪拌冷却を続け室温まで冷却し、乳液の性状（水中油乳化剤形）の身体用のフレグランス１を作成した。 A body fragrance, which is a cosmetic product of the present invention, was prepared according to the formulation shown below. That is, the components of A, B, and C are heated to 80 ° C., and gradually added to B to emulsify. Further, while continuing to stir, C is added to neutralize, and the mixture is cooled by stirring. Then, stirring and cooling were continued, and the mixture was cooled to room temperature. Thus, a fragrance 1 for a body having the properties of an emulsion (oil-in-water emulsifier type) was prepared.
イ）
グリセリルトリイソステアレート ２ 質量％
ＰＯＥ（６）ソルビタンモノオレート ０．５質量％
（ＨＬＢ１０）
ロ）
１，３−ブタンジオール ８ 質量％
エタノール １５ 質量％
「カーボポール１３８２」の１％水溶液 ５ 質量％
「カーボポールＵ−１０」の１％水溶液 ４５ 質量％
キサンタンガム ０．１質量％
ハ）
水 ２２．４質量％
水酸化カリウム１０％水溶液 ２ 質量％
ニ
シトラス系香調の香料 ８ 質量％
I)
Glyceryl triisostearate 2% by mass
POE (6) sorbitan monooleate 0.5% by mass
(HLB10)
B)
1,3-butanediol 8% by mass
Ethanol 15 mass%
1% aqueous solution of “Carbopol 1382” 5% by mass
45% by weight of 1% aqueous solution of “Carbopol U-10”
Xanthan gum 0.1% by mass
C)
22.4% by weight of water
Potassium hydroxide 10% aqueous solution 2% by mass
Nicitrus scented fragrance 8% by mass
＜試験例１＞
身体用のフレグランス１の香気の経時変化について、香粧品０．１ｍｌをシリコーンラバー上に延展させ、オープン系に保ち、一定時間毎に調香師に、瓶に密閉して保存したフレグランスとの香りの変化を判定してもらった。香りの変化は香調と香りの強さとして評価してもらった。同時に、フレグランス１の香料８％の一部を水に置換して６％に減量して作成した比較例１、グリセリルトリイソステアレートをオリーブ油に置換した比較例２、グリセリルトリイソステアレートをグリセリルトリステアレートに置換した比較例３も作成し、同様に評価した。結果を表１に示す。これより、本発明の香粧品は香気が安定して長時間持続していることが判る。
<Test Example 1>
For the fragrance of body fragrance 1 over time, 0.1 ml of cosmetic product was spread on a silicone rubber, kept open, and perfumed with a fragrance that was kept sealed in a bottle at regular intervals. We had you judge change of. The change in scent was evaluated as scent and strength. At the same time, comparative example 1 was prepared by substituting 8% of fragrance 1 fragrance with water and reduced to 6%, comparative example 2 in which glyceryl triisostearate was replaced with olive oil, and glyceryl triisostearate was glyceryl. Comparative Example 3 substituted with tristearate was also prepared and evaluated in the same manner. The results are shown in Table 1. From this, it can be seen that the cosmetic product of the present invention has a stable aroma and lasts for a long time.
＜試験例２＞
試験例１の身体用のフレグランス１、比較例１、比較例２及び比較例３を用いて、エステティックでの身体部分（デコルテ部分）への擦過を１０分間行い、その前後の唾液中のプラステロン硫酸の濃度の変化率を求めた。例数は各４例とした。プラステロン硫酸濃度はキットを用いて、サンドウィッチ抗原抗体法により、ペルオキシダーゼ標識抗体を用いて測定した。濃度の変化は、施術後の吸光度を施術前の吸光度で除して、百を乗じて上昇率として求めた。結果を表２に示す。これより、本発明の香粧品を用いると、心の安定性が向上してプラステロン硫酸の濃度が上昇していることが判る。
<Test Example 2>
Using the fragrance 1 for body of Test Example 1, Comparative Example 1, Comparative Example 2 and Comparative Example 3, the body part (decorte part) was rubbed for 10 minutes with esthetics, and the saliva before and after that was added. The rate of change in the concentration of teron sulfate was determined. The number of examples was 4 each. Plasterone sulfate concentration was measured using a peroxidase-labeled antibody by a sandwich antigen antibody method using a kit. The change in concentration was determined by dividing the absorbance after the treatment by the absorbance before the treatment and multiplying by 100 to obtain the rate of increase. The results are shown in Table 2. From this, it can be seen that when the cosmetic product of the present invention is used, the stability of the heart is improved and the concentration of plasterone sulfate is increased.
実施例１と同様に、下記の処方に従って本発明の香粧品である、身体用のフレグランス２を作成した。このものを試験例１と同様に評価したところ、表３の結果を得た。これより、分岐脂肪酸のトリグリセライドとしては、グリセリルトリイソステアレートが好ましいことが判る。 In the same manner as in Example 1, a fragrance 2 for body, which is a cosmetic product of the present invention, was prepared according to the following formulation. When this was evaluated in the same manner as in Test Example 1, the results shown in Table 3 were obtained. From this, it can be seen that glyceryl triisostearate is preferable as the triglyceride of the branched fatty acid.
イ）
グリセリルトリイソオクタネート ２ 質量％
ＰＯＥ（６）ソルビタンモノオレート ０．５質量％
ロ）
１，３−ブタンジオール ８ 質量％
エタノール １５ 質量％
「カーボポール１３８２」の１％水溶液 ５ 質量％
「カーボポールＵ−１０」の１％水溶液 ４５ 質量％
キサンタンガム ０．１質量％
ハ）
水 ２２．４質量％
水酸化カリウム１０％水溶液 ２ 質量％
ニ
シトラス系香調の香料 ８ 質量％
I)
Glyceryl triisooctanoate 2% by mass
POE (6) sorbitan monooleate 0.5% by mass
B)
1,3-butanediol 8% by mass
Ethanol 15 mass%
1% aqueous solution of “Carbopol 1382” 5% by mass
45% by weight of 1% aqueous solution of “Carbopol U-10”
Xanthan gum 0.1% by mass
C)
22.4% by weight of water
Potassium hydroxide 10% aqueous solution 2% by mass
Nicitrus scented fragrance 8% by mass
実施例１と同様に、下記の処方に従って本発明の香粧品である、身体用のフレグランス３を作成した。このものを試験例１と同様に評価したところ、表４の結果を得た。これより、界面活性剤としては、ＨＬＢ９〜１２の非イオン界面活性剤を用いることが好ましが好ましいことが判る。 In the same manner as in Example 1, a fragrance 3 for body, which is a cosmetic product of the present invention, was prepared according to the following formulation. When this was evaluated in the same manner as in Test Example 1, the results shown in Table 4 were obtained. From this, it can be seen that it is preferable to use a nonionic surfactant of HLB 9-12 as the surfactant.
イ）
グリセリルトリイソステアレート ２ 質量％
ＰＯＥ（２０）ソルビタンモノオレート ０．５質量％
（ＨＬＢ１５）
ロ）
１，３−ブタンジオール ８ 質量％
エタノール １５ 質量％
「カーボポール１３８２」の１％水溶液 ５ 質量％
「カーボポールＵ−１０」の１％水溶液 ４５ 質量％
キサンタンガム ０．１質量％
ハ）
水 ２２．４質量％
水酸化カリウム１０％水溶液 ２ 質量％
ニ
シトラス系香調の香料 ８ 質量％
I)
Glyceryl triisostearate 2% by mass
POE (20) sorbitan monooleate 0.5% by mass
(HLB15)
B)
1,3-butanediol 8% by mass
Ethanol 15 mass%
1% aqueous solution of “Carbopol 1382” 5% by mass
45% by weight of 1% aqueous solution of “Carbopol U-10”
Xanthan gum 0.1% by mass
C)
22.4% by weight of water
Potassium hydroxide 10% aqueous solution 2% by mass
Nicitrus scented fragrance 8% by mass
実施例１と同様に、下記の処方に従って本発明の香粧品である、身体用のフレグランス４を作成した。このものを試験例１と同様に評価したところ、表５の結果を得た。これより、アルキル変性カルボキシビニルポリマー及び／又はその塩と、カルボキシビニルポリマー及び／又はその塩とを組み合わせることが好ましいことが判る。 In the same manner as in Example 1, a fragrance 4 for the body, which is a cosmetic product of the present invention, was prepared according to the following formulation. When this was evaluated in the same manner as in Test Example 1, the results shown in Table 5 were obtained. From this, it can be seen that it is preferable to combine the alkyl-modified carboxyvinyl polymer and / or salt thereof with the carboxyvinyl polymer and / or salt thereof.
イ）
グリセリルトリイソステアレート ２ 質量％
ＰＯＥ（６）ソルビタンモノオレート ０．５質量％
ロ）
１，３−ブタンジオール ８ 質量％
エタノール １５ 質量％
「カーボポール１３８２」の１％水溶液 ５０ 質量％
キサンタンガム ０．１質量％
ハ）
水 ２２．４質量％
水酸化カリウム１０％水溶液 ２ 質量％
ニ
シトラス系香調の香料 ８ 質量％
I)
Glyceryl triisostearate 2% by mass
POE (6) sorbitan monooleate 0.5% by mass
B)
1,3-butanediol 8% by mass
Ethanol 15 mass%
1% aqueous solution of “Carbopol 1382” 50% by mass
Xanthan gum 0.1% by mass
C)
22.4% by weight of water
Potassium hydroxide 10% aqueous solution 2% by mass
Nicitrus scented fragrance 8% by mass
実施例１と同様に、下記の処方に従って本発明の香粧品である、身体用のフレグランス５を作成した。このものを試験例１と同様に評価したところ、表６の結果を得た。これより、アルキル変性カルボキシビニルポリマー及び／又はその塩と、カルボキシビニルポリマー及び／又はその塩とを組み合わせることが好ましいことが判る。 In the same manner as in Example 1, a fragrance 5 for body, which is a cosmetic product of the present invention, was prepared according to the following formulation. When this was evaluated in the same manner as in Test Example 1, the results shown in Table 6 were obtained. From this, it can be seen that it is preferable to combine the alkyl-modified carboxyvinyl polymer and / or salt thereof with the carboxyvinyl polymer and / or salt thereof.
イ）
グリセリルトリイソステアレート ２ 質量％
ＰＯＥ（６）ソルビタンモノオレート ０．５質量％
ロ）
１，３−ブタンジオール ８ 質量％
エタノール １５ 質量％
「ペムレンＴＲ−１」の１％水溶液 ５０ 質量％
キサンタンガム ０．１質量％
ハ）
水 ２２．４質量％
水酸化カリウム１０％水溶液 ２ 質量％
ニ
シトラス系香調の香料 ８ 質量％
I)
Glyceryl triisostearate 2% by mass
POE (6) sorbitan monooleate 0.5% by mass
B)
1,3-butanediol 8% by mass
Ethanol 15 mass%
1% aqueous solution of “Pemlen TR-1” 50% by mass
Xanthan gum 0.1% by mass
C)
22.4% by weight of water
Potassium hydroxide 10% aqueous solution 2% by mass
Nicitrus scented fragrance 8% by mass
実施例１と同様に、下記の処方に従って本発明の香粧品である、身体用のフレグランス６を作成した。このものを試験例１と同様に評価したところ、表７の結果を得た。これより、アルキル変性カルボキシビニルポリマー及び／又はその塩と、カルボキシビニルポリマー及び／又はその塩とを組み合わせることが好ましいことが判る。 In the same manner as in Example 1, a fragrance 6 for the body, which is a cosmetic product of the present invention, was prepared according to the following formulation. When this product was evaluated in the same manner as in Test Example 1, the results shown in Table 7 were obtained. From this, it can be seen that it is preferable to combine the alkyl-modified carboxyvinyl polymer and / or salt thereof with the carboxyvinyl polymer and / or salt thereof.
イ）
グリセリルトリイソステアレート ２ 質量％
ＰＯＥ（６）ソルビタンモノオレート ０．５質量％
ロ）
１，３−ブタンジオール ８ 質量％
エタノール １５ 質量％
「ペムレンＴＲ−２」の１％水溶液 ５０ 質量％
キサンタンガム ０．１質量％
ハ）
水 ２２．４質量％
水酸化カリウム１０％水溶液 ２ 質量％
ニ
シトラス系香調の香料 ８ 質量％
I)
Glyceryl triisostearate 2% by mass
POE (6) sorbitan monooleate 0.5% by mass
B)
1,3-butanediol 8% by mass
Ethanol 15 mass%
1% aqueous solution of “Pemlen TR-2” 50% by mass
Xanthan gum 0.1% by mass
C)
22.4% by weight of water
Potassium hydroxide 10% aqueous solution 2% by mass
Nicitrus scented fragrance 8% by mass
本発明は、エステティックに好適な香粧品に応用できる。 The present invention can be applied to cosmetics suitable for aesthetics.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004143165A JP4332468B2 (en) | 2004-05-13 | 2004-05-13 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004143165A JP4332468B2 (en) | 2004-05-13 | 2004-05-13 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005325039A JP2005325039A (en) | 2005-11-24 |
| JP4332468B2 true JP4332468B2 (en) | 2009-09-16 |
Family
ID=35471681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004143165A Expired - Lifetime JP4332468B2 (en) | 2004-05-13 | 2004-05-13 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4332468B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007210959A (en) * | 2006-02-10 | 2007-08-23 | Shiseido Co Ltd | External composition for skin |
| DE102011085509A1 (en) * | 2011-10-31 | 2013-05-02 | Beiersdorf Ag | Fixation of perfume on wet skin |
| JP6549369B2 (en) * | 2014-10-28 | 2019-07-24 | 花王株式会社 | Sheet-like cosmetics |
-
2004
- 2004-05-13 JP JP2004143165A patent/JP4332468B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005325039A (en) | 2005-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6070571B2 (en) | Deodorant composition | |
| JP2010037272A (en) | Cosmetic suitable for massage | |
| JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
| JP2008019230A5 (en) | ||
| JP2013053088A (en) | Powder-containing external skin care preparation | |
| JP2007137822A (en) | Skin care preparation which is suitable for massage | |
| JP4332468B2 (en) | Cosmetics | |
| JP5340588B2 (en) | Cosmetics for correcting pores | |
| JP2008222653A (en) | External preparation for skin with moisture retainability | |
| JP2009040738A (en) | Water-in-oil emulsifier type external preparation for skin | |
| ES2924128T3 (en) | deodorant products | |
| JP4801418B2 (en) | Cosmetics for nail care | |
| JP4266904B2 (en) | Emulsified cosmetics | |
| JP4338561B2 (en) | Post form cosmetic | |
| JP4842170B2 (en) | Solid powder cosmetics | |
| JP2015229695A (en) | O/w emulsion composition | |
| JP5222465B2 (en) | Skin external preparation suitable for esthetics | |
| JP2007112766A (en) | Cosmetic for body | |
| JP5635223B2 (en) | Skin external preparation suitable for esthetic treatment | |
| JP6157185B2 (en) | Skin external preparation with cooling sensation | |
| JP5398053B2 (en) | Massage cosmetics | |
| JP2008150329A (en) | Skin care preparation, suitable for cosmetic | |
| JP2007099658A (en) | Oil-in-water type moisturizing skin care external preparation | |
| JP2007277192A5 (en) | ||
| JP2005162703A (en) | Facial wash |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070320 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070320 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090305 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090317 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090518 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090616 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090622 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150626 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |